Search

everythinglearnresearchcommunity

for

Search:↓

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Microneedle patches could replace injections but need more development for better use in medicine.

ASC-CM is more effective than EV for treating osteoarthritis.

New therapies are being developed that target integrin pathways to treat various diseases.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Bacterial extracellular vesicles could revolutionize regenerative medicine but need safety improvements.

A new lab-grown lung model helps study adenoviruses and test antiviral drugs.

Sericin from silk cocoons could be a promising drug delivery tool, but stability and consistency need improvement.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Turning off a specific gene in stem cells speeds up skin healing by helping cells move better.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Skin stretching can improve vaccine delivery through hair follicles and boost immune response.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Healthcare workers with a positive COVID-19 test were more likely to report long-COVID symptoms.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

COVID-19 vaccination is generally safe for people with Hidradenitis Suppurativa.

COVID-19 may cause hair loss by affecting hair follicles.

A 6-year-old girl experienced temporary hair loss after mild COVID-19, which improved naturally in 8 months.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.

Post-COVID conditions increase health care needs for six months after infection.